Company Introduction

Agilex Biolabs, as Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials specialises in both LC-MS/MS and immunoassay/immunobiology services. We operate a fully quality-assured, FDA-inspected laboratory in Australia (ISO/IEC17025 and OECD GLP), offering bioanalysis for small molecules and biologics for PK, PD, immunogenicity, and biomarkers as well as an immunobiology service for evaluation of immunological endpoints by flow cytometry and cell-based assays. Agilex Biolabs would like to engage biotech and pharma companies interested in utilising Australia as their early phase clinical trial location to access regulatory speed, R&D Tax cash-back incentives and premium quality service.

Brief description of main products or services 

Agilex Biolabs specialises in both LC-MS/MS and immunoassay/immunobiology services. We operate a fully quality-assured, FDA-inspected laboratory in Australia (ISO/IEC17025 and OECD GLP), offering bioanalysis for small molecules and biologics for PK, PD, immunogenicity, and biomarkers as well as an immunobiology service for evaluation of immunological endpoints by flow cytometry and cell-based assays.

We have strong biosimilar, oncology and early phase experience, and would like to engage with biotech companies interested in utilising Australia for their early phase clinical trials to access regulatory speed, R&D Tax refunds, premium quality service, and our 20-year-track-record. Our LC-MS/MS experience includes NCEs, sugars, nucleotides, enantiomers, steroids, prodrugs, peptides, immunosuppressants, nanoparticles, neurotransmitters, oligonucleotides, and polymeric mixtures.

Our biologics experience entails PK analysis using colorimetric, fluorescence or chemiluminescence detection for recombinant or fusion proteins, monoclonal antibodies, ADCs, Immunogenicity testing, biomarker analysis, PBMC blood stimulation assays and immunological assessments by flow cytometry.